Orchestra BioMed Holdings OBIO
NASDAQ OBIO
$6.01 +0.28 (+4.89%)
At close: Nov 11, 2026 · 4:00 PM EST

Orchestra BioMed Holdings (OBIO) Convertible Debt (2026)

Updated

Orchestra BioMed Holdings' Convertible Debt was $20.44 million in Q2 2026.

Analysis

Orchestra BioMed Holdings (OBIO) Convertible Debt (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn
10 Orchestra BioMed Holdings 352.13 Mn -49.69 Mn 63,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 21.15 Mn
Jun 30, 2026 20.44 Mn
API Access

Orchestra BioMed Holdings Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=OBIO&period=max&api_key=YOUR_API_KEY